Cargando…

Evaluation of coagulation parameters in patients with parathyroid adenoma

Parathyroid adenoma is responsible for 80–85% of cases of primary hyperparathyroidism. Increased fibrinogen levels in patients with adenoma may increase the risk of atherosclerosis and cardiovascular events. The aim of this study was to investigate the relationship between coagulation parameters and...

Descripción completa

Detalles Bibliográficos
Autores principales: Alay, Murat, Ercek, Berrak Mermit, Sonmez, Gulcin Miyase, Sakin, Aysegul, Ucler, Rifki, Yildiz, Saliha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645620/
https://www.ncbi.nlm.nih.gov/pubmed/33154484
http://dx.doi.org/10.1038/s41598-020-76167-2
_version_ 1783606666347937792
author Alay, Murat
Ercek, Berrak Mermit
Sonmez, Gulcin Miyase
Sakin, Aysegul
Ucler, Rifki
Yildiz, Saliha
author_facet Alay, Murat
Ercek, Berrak Mermit
Sonmez, Gulcin Miyase
Sakin, Aysegul
Ucler, Rifki
Yildiz, Saliha
author_sort Alay, Murat
collection PubMed
description Parathyroid adenoma is responsible for 80–85% of cases of primary hyperparathyroidism. Increased fibrinogen levels in patients with adenoma may increase the risk of atherosclerosis and cardiovascular events. The aim of this study was to investigate the relationship between coagulation parameters and parathyroid adenoma. A prospective study included 28 female patients with parathyroid adenoma aged 40–88 years and 27 age-matched healthy controls. The coagulation parameters were assessed for each participant. The mean ages of the patient and control groups were 57.7 ± 10.9 and 53.3 ± 9.31 years, respectively. The mean level of protein S activity was 65.79 ± 13.78 in the patient group and 77.00 ± 15.72 in the control group, and the difference was statistically significant (p = 0.013). The mean fibrinogen levels of the patient and control groups were 338.78 ± 63.87 mg/dL and 304.30 ± 45.67 mg/dL, respectively, and a significant difference was found (p = 0.041). However, no significant difference was evident between the two groups with regard to the D-dimer (p = 0.238), aPTT (p = 0.645), INR (p = 0.406), protein C (p = 0.076), and AT-III (p = 0.180) levels. A positive correlation was observed between adenoma volume and fibrinogen in the patient group (r = 0.711, p = 0.001). The protein S levels were lower and the fibrinogen levels higher in the patients with parathyroid adenoma.
format Online
Article
Text
id pubmed-7645620
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-76456202020-11-06 Evaluation of coagulation parameters in patients with parathyroid adenoma Alay, Murat Ercek, Berrak Mermit Sonmez, Gulcin Miyase Sakin, Aysegul Ucler, Rifki Yildiz, Saliha Sci Rep Article Parathyroid adenoma is responsible for 80–85% of cases of primary hyperparathyroidism. Increased fibrinogen levels in patients with adenoma may increase the risk of atherosclerosis and cardiovascular events. The aim of this study was to investigate the relationship between coagulation parameters and parathyroid adenoma. A prospective study included 28 female patients with parathyroid adenoma aged 40–88 years and 27 age-matched healthy controls. The coagulation parameters were assessed for each participant. The mean ages of the patient and control groups were 57.7 ± 10.9 and 53.3 ± 9.31 years, respectively. The mean level of protein S activity was 65.79 ± 13.78 in the patient group and 77.00 ± 15.72 in the control group, and the difference was statistically significant (p = 0.013). The mean fibrinogen levels of the patient and control groups were 338.78 ± 63.87 mg/dL and 304.30 ± 45.67 mg/dL, respectively, and a significant difference was found (p = 0.041). However, no significant difference was evident between the two groups with regard to the D-dimer (p = 0.238), aPTT (p = 0.645), INR (p = 0.406), protein C (p = 0.076), and AT-III (p = 0.180) levels. A positive correlation was observed between adenoma volume and fibrinogen in the patient group (r = 0.711, p = 0.001). The protein S levels were lower and the fibrinogen levels higher in the patients with parathyroid adenoma. Nature Publishing Group UK 2020-11-05 /pmc/articles/PMC7645620/ /pubmed/33154484 http://dx.doi.org/10.1038/s41598-020-76167-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Alay, Murat
Ercek, Berrak Mermit
Sonmez, Gulcin Miyase
Sakin, Aysegul
Ucler, Rifki
Yildiz, Saliha
Evaluation of coagulation parameters in patients with parathyroid adenoma
title Evaluation of coagulation parameters in patients with parathyroid adenoma
title_full Evaluation of coagulation parameters in patients with parathyroid adenoma
title_fullStr Evaluation of coagulation parameters in patients with parathyroid adenoma
title_full_unstemmed Evaluation of coagulation parameters in patients with parathyroid adenoma
title_short Evaluation of coagulation parameters in patients with parathyroid adenoma
title_sort evaluation of coagulation parameters in patients with parathyroid adenoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645620/
https://www.ncbi.nlm.nih.gov/pubmed/33154484
http://dx.doi.org/10.1038/s41598-020-76167-2
work_keys_str_mv AT alaymurat evaluationofcoagulationparametersinpatientswithparathyroidadenoma
AT ercekberrakmermit evaluationofcoagulationparametersinpatientswithparathyroidadenoma
AT sonmezgulcinmiyase evaluationofcoagulationparametersinpatientswithparathyroidadenoma
AT sakinaysegul evaluationofcoagulationparametersinpatientswithparathyroidadenoma
AT uclerrifki evaluationofcoagulationparametersinpatientswithparathyroidadenoma
AT yildizsaliha evaluationofcoagulationparametersinpatientswithparathyroidadenoma